Literature DB >> 25591858

A comparison of glide force characteristics between 2 prefilled insulin lispro pens.

Tina M Rees1, Amanda H Lennartz2, Debra A Ignaut2.   

Abstract

Glide force, average glide force, and glide force variability of the insulin lispro 200 units/mL pen (Eli Lilly and Company, Indianapolis, IN, USA) were compared to the Humalog KwikPen 100 units/mL pen (hereafter, KwikPen; Eli Lilly and Company, Indianapolis, IN, USA). Data were collected on 2 doses, 2 injection speeds, and 2 needle types. Insulin lispro 200 units/mL pen showed significantly lower maximum glide force, average glide force, and glide force variability than the KwikPen across all combinations of dose size, dose speed, and needle type. The lower glide force observed with the insulin lispro 200 units/mL pen offers another treatment option for patients with type 1 or type 2 diabetes who require greater than 20 units of mealtime insulin daily.
© 2015 Diabetes Technology Society.

Entities:  

Keywords:  Humalog® KwikPen® 100 units/mL; average glide force; glide force; glide force variability; insulin lispro 200 units/mL; insulin pen

Mesh:

Substances:

Year:  2015        PMID: 25591858      PMCID: PMC4604579          DOI: 10.1177/1932296814567533

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  18 in total

Review 1.  Obesity and insulin resistance.

Authors:  B B Kahn; J S Flier
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Limited joint mobility in non-insulin-dependent diabetic (NIDDM) patients: correlation to control of diabetes, atherosclerotic vascular disease, and other diabetic complications.

Authors:  P E Arkkila; I M Kantola; J S Viikari
Journal:  J Diabetes Complications       Date:  1997 Jul-Aug       Impact factor: 2.852

3.  Engineering study comparing injection force and dose accuracy between two prefilled insulin injection pens.

Authors:  Debra A Ignaut; Michael R Opincar; Paula E Clark; Melanie K Palaisa; Sheila M Lenox
Journal:  Curr Med Res Opin       Date:  2009-12       Impact factor: 2.580

4.  Injection force of SoloSTAR® compared with other disposable insulin pen devices at constant volume flow rates.

Authors:  Thomas van der Burg
Journal:  J Diabetes Sci Technol       Date:  2011-01-01

5.  Poiseuille and his law.

Authors:  J Pfitzner
Journal:  Anaesthesia       Date:  1976-03       Impact factor: 6.955

6.  Prefilled insulin device with reduced injection force: patient perception and accuracy.

Authors:  A Pfützner; T Reimer; C Hohberg; L P F Frøkjaer; C Jørgensen
Journal:  Curr Med Res Opin       Date:  2008-07-31       Impact factor: 2.580

7.  The presence of limited joint mobility is significantly associated with multiple digit involvement by stenosing flexor tenosynovitis in diabetics.

Authors:  Makoto Kameyama; Shu Meguro; Osamu Funae; Yoshihito Atsumi; Hiroyasu Ikegami
Journal:  J Rheumatol       Date:  2009-06-16       Impact factor: 4.666

8.  Filling 'gaps' in strength data for design.

Authors:  Laura Peebles; Beverley Norris
Journal:  Appl Ergon       Date:  2003-01       Impact factor: 3.661

9.  Reduced risk of hypoglycemia with insulin degludec versus insulin glargine in patients with type 2 diabetes requiring high doses of basal insulin: a meta-analysis of 5 randomized begin trials.

Authors:  Helena W Rodbard; Stephen Gough; Wendy Lane; Lars Korsholm; Ditte-Marie Bretler; Yehuda Handelsman
Journal:  Endocr Pract       Date:  2014-04       Impact factor: 3.443

10.  Musculoskeletal complications in type 1 diabetes.

Authors:  Mary E Larkin; Annette Barnie; Barbara H Braffett; Patricia A Cleary; Lisa Diminick; Judy Harth; Patricia Gatcomb; Ellen Golden; Janie Lipps; Gayle Lorenzi; Carol Mahony; David M Nathan
Journal:  Diabetes Care       Date:  2014-04-10       Impact factor: 19.112

View more
  4 in total

1.  Attributes Influencing Insulin Pen Preference Among Caregivers and Patients With Diabetes Who Require Greater Than 20 Units of Mealtime Insulin.

Authors:  Tao Wang; Kenneth A Conrad; Kate van Brunt; Tina M Rees
Journal:  J Diabetes Sci Technol       Date:  2016-06-28

Review 2.  A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus.

Authors:  Riccardo Candido; Kathleen Wyne; Ester Romoli
Journal:  Diabetes Ther       Date:  2018-04-13       Impact factor: 2.945

3.  Patient Preferences and Health State Utilities Associated with Mealtime Insulin Concentrations Among Patients with Diabetes in Italy.

Authors:  Louis S Matza; Beatrice Osumili; Katie D Stewart; Magaly Perez-Nieves; Jessica Jordan; Giovanni Biricolti; Ester Romoli; Serena Losi; Silvia Del Santo; Erik Spaepen; Gordon Parola; Hayley Karn; Kristina S Boye
Journal:  Diabetes Ther       Date:  2019-11-23       Impact factor: 2.945

4.  Profile of Patients with Diabetes Treated with Insulin Lispro 200 U/ml: A Real-World Study from Spain.

Authors:  Miriam Rubio de Santos; Esther Artime; Natalia Duque; Silvia Díaz-Cerezo; Erik Spaepen; Ágata Carreño; Alberto Fernández
Journal:  Diabetes Ther       Date:  2022-04-21       Impact factor: 3.595

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.